Statistical Approaches for studying the safety and effectiveness of medicines

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

When medicines first reach the market many of the potential adverse reactions are unknown. Clinical trials of medicines often exclude elderly patients and patients with multiple chronic diseases who are at higher risk of adverse drug reactions. This research aims to improve medicine safety by developing statistical methods to detect and validate medication safety signals and to identify patients who are at high risk of adverse reactions to medicines.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2016

Funding Scheme: Early Career Fellowships

Funding Amount: $307,946.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biostatistics

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

adverse drug reactions | biostatistics | drug safety | pharmacoepidemiology | surveillance